The Department of Health and Human Services is reevaluating a $590 million contract for avian influenza mRNA vaccines that the prior administration struck with Moderna, Bloomberg first reported on ...

An avian flu vaccine contract with Moderna may be suspended, pending review of the contract by the current administration, according to a recent Reuters news story. The vaccine contract was ...

An avian influenza vaccine for layers, broilers, and practical for farmers was developed thanks to innovative technology ...

The 1918 flu pandemic, also known as the Spanish flu, caught the world by surprise just as the First World War was coming to ...

Moderna’s mRNA-based bird flu vaccine mRNA-1018 is undergoing a Phase 1/2 study targeting H5 and H7 avian influenza viruses. In January 2025, the US Department of Health and Human Services (HHS ...

Notably, Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses, or bird flu. It primarily affects birds, but it is closely monitored due to the risk of mutating and spreading ...

Avian influenza—which has devastated poultry flocks, wildlife populations and increasingly poses a public health risk—has now been confirmed in wild bobcats in New York state.

Minnesota’s State Veterinarian Brian Hoefs said that declaring the state's poultry free of avian influenza to this point is a ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

The deadly H7N9 strain was detected on a poultry farm in Noxubee, Mississippi, last week, for the first time since 2017.